About Christopher Visioli
Christopher Visioli is a chief financial officer at Metsera.
Form D filings also name Christopher Visioli as an executive officer at Areteia Therapeutics.
Christopher Visioli reports to the SEC as an officer of 3 public companies, including Population Health Investment Co. (PHIC) and Medicines (MDCO).
Christopher Visioli first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Visioli in the role, so the role may have started earlier or lasted longer.
PI
Population Health Investment Co., Inc.
Chief Financial Officer
2020 · Public company (PHIC)
MC
Medicines Co.
Chief Financial Officer
2018 – 2020 · Public company (MDCO)
Key Colleagues at Startups
The people Christopher Visioli works with at each company, as listed on that company's latest Form D.
Metsera, Inc. · Form D, Nov 20, 2024
KB
Kristina Burow
Director
BH
Brian Hubbard
Executive officer
CB
Christopher Bernard
Chief Executive Officer and director
SM
Steven Marso
Executive officer
CM
Clive Meanwell
Director
PB
Paul Berns
Director
JP
Joshua Pinto
Director
Areteia Therapeutics, Inc. · Form D, Jul 14, 2022
JB
Jorge Bartolome
Director
SB
Stephen Butts
Director
BG
Benjamin Gomez
Director
AK
Adam Koppel
Director
IR
Ian Read
Director
PB
Paul Berns
Director
CC
Christopher Cox
General Counsel
WB
Whit Bernard
Executive officer
MB
Michael Bozik
Director